Who is sponsoring NCT05730790?

NCT05730790 is sponsored by Tan Tock Seng Hospital.

What drugs are being tested in NCT05730790?

Interventions in NCT05730790: Cognitive-motor dual task training (DTT), Cognitive single task training (CSTT), Motor single task training (MSTT).

What condition does NCT05730790 study?

NCT05730790 studies Mild Cognitive Impairment.

Is NCT05730790 still recruiting?

NCT05730790 is currently status unknown. Last updated 16 February 2023.

Last reviewed 2023-02-16 · How we verify

NCT05730790

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Immersive Virtual Reality for Dual-task Training in Older Adults With Mild Cognitive Impairment: A Randomized Controlled Trial

Status unknown NA Last updated 16 February 2023

What this trial tests

NA trial testing Cognitive-motor dual task training (DTT) in Mild Cognitive Impairment in 54 participants. Status unknown.

Timeline

31 March 2021

Primary endpoint
31 March 2023

1 September 2023

Quick facts

Lead sponsor	Tan Tock Seng Hospital
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	54
Start date	31 March 2021
Primary completion	31 March 2023
Estimated completion	1 September 2023
Sites	1 location across Singapore

Drugs / interventions tested

Cognitive-motor dual task training (DTT)
Cognitive single task training (CSTT)
Motor single task training (MSTT)

Conditions studied

Mild Cognitive Impairment — all drugs for Mild Cognitive Impairment →

Sponsor

Tan Tock Seng Hospital

Who can join

Adults 60 to 80, any sex, with Mild Cognitive Impairment. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Mild cognitive impairment (MCI) is a pre-dementia state marked by a higher risk of conversion to dementia. Presently, strategies to delay the progression of MCI to dementia, such as routine exercise and cognitive activities, are limited and only moderately efficacious. Cognitive-motor dual task training, enhanced in a virtual reality environment, is a novel intervention for individuals with MCI.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Exergaming for dementia and mild cognitive impairment.
Voinescu A, Papaioannou T, Petrini K, Stanton Fraser D. · · 2024 · cited 9× · PMID 39319863 · DOI 10.1002/14651858.cd013853.pub2

Verify or expand the search:

Other recruiting trials for Mild Cognitive Impairment

Currently open trials in the same condition.

NCT05791994 — EVASION: Effect of VisuAl Stimulation on attentION · NA · recruiting
NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
NCT07220694 — Effects of Sabroxy® Supplementation on Insulin Resistance and Cognitive Function in Adults With Mild Cognitive Impairmen · NA · recruiting
NCT06983769 — CPAP vs MAD for OSA in Patients With Cognitive Impairment. A Randomized Clinical Trial · NA · recruiting
NCT07318038 — The Use of Rhythmic Light Therapy in Mild Cognitive Impairment · NA · recruiting

Other Tan Tock Seng Hospital trials

Trials by the same sponsor.

NCT07078240 — Examining Nurses' Trust and Acceptance of FAIR, an AI-powered Falls Risk Recommender · NA · not yet recruiting
NCT07257341 — Pilot Study of Normative Range of Field of Binocular Single Vision in Adults in Singapore · recruiting
NCT07151729 — Use of Anodal tDCS to Enhance Upper Limb Recovery in Stroke · NA · recruiting
NCT07122752 — Feasibility and Outcomes of 3D-printed External Cranial Orthosis After Craniectomy · active not recruiting
NCT07255859 — CRYSTALSIGHT Cohort 2.0 · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05730790 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Tan Tock Seng Hospital
Last refreshed: 16 February 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05730790.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing